Location History:
- Rehovot, IL (1992 - 2003)
- Tel Aviv, IL (1976 - 2005)
Company Filing History:
5 out of 1,168 
2 out of 1,627 
3 out of 832,761 Years Active: 1976-2005
Title: Yehuda Mazur: Innovator in Anti-Cancer and Antiviral Research
Introduction
Yehuda Mazur is a prominent inventor based in Rehovot, Israel, known for his significant contributions to the fields of anti-cancer and antiviral research. With a total of 8 patents to his name, Mazur has made remarkable strides in developing innovative compounds that hold promise for medical applications.
Latest Patents
Among his latest patents, Mazur has developed Helianthrone derivatives as anti-cancer agents. These compounds, which include hypericin and its derivatives, are designed to inhibit angiogenesis and prevent the formation of metastases. They are also useful in treating angiogenesis-associated ophthalmologic disorders without the need for light irradiation. Additionally, he has created novel antiviral compounds, which are mono- or dicarboxylic acid esters of hypericin. These compounds can be formulated into pharmaceutical compositions and are intended for use in various therapeutic applications.
Career Highlights
Throughout his career, Mazur has worked with Yeda Research and Development Co. Ltd., where he has contributed to groundbreaking research and development in his field. His work has not only advanced scientific understanding but has also paved the way for potential new treatments for serious health conditions.
Collaborations
Mazur has collaborated with notable individuals in his field, including Gad Lavie and Aureliu J Acher. These partnerships have further enhanced the impact of his research and innovations.
Conclusion
Yehuda Mazur's work exemplifies the spirit of innovation in the medical field, particularly in the development of anti-cancer and antiviral agents. His contributions continue to inspire advancements in therapeutic solutions for critical health challenges.